Patents by Inventor Morio Nagira

Morio Nagira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240190975
    Abstract: The chimeric antigen receptor that recognizes CCR8 as an antigen of the present invention has cytotoxic activity against CCR8-expressing cells by being expressed in effector cells.
    Type: Application
    Filed: March 31, 2022
    Publication date: June 13, 2024
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Tetsuya Yoshida, Mai Yoshikawa, Miya Haruna, Morio Nagira, Koji Takahashi, Marina Hayashida, Hiroto Miwa, Yudai Sonoda, Naganari Ohkura, Shimon Sakaguchi, Hisashi Wada
  • Publication number: 20220064312
    Abstract: Disclosed is a novel anti-CCR8 antibody. The antibody can be used for treating or preventing cancers or the like.
    Type: Application
    Filed: December 27, 2019
    Publication date: March 3, 2022
    Applicants: Shionogi & Co., Ltd., Osaka University
    Inventors: Mai Yoshikawa, Tatsuya Takahashi, Junji Onoda, Sunao Imai, Etsuo Nakamura, Kentaro Furukawa, Tsuguo Miyauchi, Tetsuya Yoshida, Morio Nagira, Naganari Ohkura, Atsushi Tanaka, Shimon Sakaguchi, Hisashi Wada, Atsunari Kawashima